Skip to main content
Displaying 1 - 9 of 9
Display:
12
24
48
Metabolism, Alcohol & Toxicity
Session 1: Identifying Patients with NASH and Significant Fibrosis: Are we doing enough?
Webcasts
View
Metabolism, Alcohol & Toxicity
Session 2: Managing patients with NASH and Significant Fibrosis – Now and in the future
Webcasts
View
Metabolism, Alcohol & Toxicity
Session 3: Treating patients with NASH and Significant Fibrosis, what the future holds?
Webcasts
View
Metabolism, Alcohol & Toxicity
Discussion
Webcasts
View
Metabolism, Alcohol & Toxicity
Panel Q/A
Webcasts
View
Metabolism, Alcohol & Toxicity
Welcome and Introduction to the Event and Keynote Speakers
Webcasts
View
Metabolism, Alcohol & Toxicity
System-based solutions for NAFLD in the UK
Webcasts
View
Metabolism, Alcohol & Toxicity
Current landscape of Non-invasive technologies and the Role of LiverMultiScan Quantitative Multiparametric MRI for Patient Ris...
Webcasts
View
Metabolism, Alcohol & Toxicity
Upcoming NASH Therapeutics; The Need for Non-Invasive Technologies
Webcasts
View
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy